R Squared’s Voyager Therapeutics VYGR Stock Holding History

R Squared’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,488	Closed	-$48.2K	–	716
2025 Q2	$48.2K	Buy	+15,488	New	+$50K	0.03%	396

Other funds holding VYGR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

R Squared's VYGR Position: Q3 2025 in Review

R Squared sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 15,488 shares — an estimated $48.2K sold.

R Squared first reported a position in VYGR in Q2 2025 and held it in 1 quarter. The position peaked at $48.2K in Q2 2025. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

R Squared reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
R Squared sold 15,488 Voyager Therapeutics shares in Q3 2025, an estimated $48.2K.
R Squared first reported a position in Voyager Therapeutics in Q2 2025 and held it in 1 quarter.
R Squared's Voyager Therapeutics position peaked at $48.2K in Q2 2025.
117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on R Squared's 13F filing for Q3 2025, filed 12 Nov 2025.